Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Reade revalidatie & reumatologie centrum te Amsterdam

Verifiedinfo

The Netherlands Admiraal Helfrichstraat 1, 1056 AA Amsterdam, The Netherlands

  • 5 trials recruiting
  • Rheumatoid arthritis · Psoriatic arthropathy · Axial spondyloarthritis
  • Adult patients

About Specializations

Reade revalidatie & reumatologie centrum te Amsterdam in Amsterdam, The Netherlands specialises in clinical trials of conditions such as Rheumatoid arthritis, Psoriatic arthropathy, Axial spondyloarthritis, Rheumatic disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Rheumatology

The medical center is at the forefront of rheumatology research, focusing on innovative treatments for rheumatoid arthritis. The center's work is pivotal in enhancing the understanding of disease mechanisms and improving patient outcomes.

  • Rheumatoid Arthritis Management
  • Inflammatory Joint Diseases
  • Autoimmune Disorders

Through its research, the center contributes significantly to the development of personalized treatment strategies, optimizing therapeutic approaches to better manage chronic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Admiraal Helfrichstraat 11056 AA AmsterdamThe Netherlands
Open in maps ↗
Recruiting now
5 trials
Conditions studied
6
Partner status
Verified

More sites in AmsterdamThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Rheumatoid arthritis

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Sint Maartenskliniek

Axial spondyloarthritis+3

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Sint Maartenskliniek

Neoplasm

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ipilimumab
  • Sponsor:Amsterdam UMC Stichting

Rheumatoid arthritis

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Reade revalidatie & reumatologie centrum te Amsterdam

Rheumatoid arthritis

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Filgotinib
  • Sponsor:Reade revalidatie & reumatologie centrum te Amsterdam

Psoriatic arthropathy

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Universitair Medisch Centrum Utrecht
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.